Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
QCLS US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
QCLS US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Q/c Technologies, Inc.
(QCLS US)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Q/c Technologies, Inc.
(QCLS US)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(407)
Expand
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
05:00PM
8-K
Entry into a Material Definitive Agreement
18 Sep
8-K
Termination of a Material Definitive Agreement
11 Sep
10-Q
Q2
ended 30 Jun 2026
12 Aug
8-K
Termination of a Material Definitive Agreement
2 Jul
10-Q
Q1
ended 31 Mar 2026
15 May
10-K/A
FY 2025
ended 31 Dec 2025
29 Apr
10-K
FY 2025
ended 31 Dec 2025
15 Apr
NT 10-K
FY 2025
ended 31 Dec 2025
31 Mar
8-K
Changes in Registrant's Certifying Accountant
13 Mar
EFFECT
Notice of effectiveness
18 Feb
CORRESP
Filing review correspondence
12 Feb
S-3
Registration statement (primary offering)
11 Feb
8-K
Entry into a Material Definitive Agreement
23 Jan
DRS
Draft registration statement
23 Jan
8-K
Entry into a Material Definitive Agreement
9 Dec 2025
424B3
Prospectus filing (Rule 424(b)(3))
1 Dec 2025
EFFECT
Notice of effectiveness
1 Dec 2025
CORRESP
Filing review correspondence
25 Nov 2025
10-Q
Q3
ended 30 Sept 2025
19 Nov 2025
Ownership Filings
(171)
Expand
Form 4
Silverman Joshua
2 Oct
Form 4/A
Silverman Joshua
2 Oct
Form 3
Ehrlichman Yossef
22 Sep
Form 3
Fagan Charles Todd
17 Aug
Form 4
Voss Chelsea Sierra
14 May
Form 4
Friscia Stephen
15 Apr
Form 4
Voss Chelsea Sierra
15 Apr
Form 4
Glass Mitchell
15 Apr
Form 4
White Billy Joe
15 Apr
Form 4
Bernstein Bruce
15 Apr
Form 4
Silverman Joshua
15 Apr
Form 4
Voss Chelsea Sierra
30 Jan
Form 3
Voss Chelsea Sierra
30 Jan
Form 4
PharmaCyte Biotech, Inc.
18 Nov 2025
SC 13D/A
Q/C TECHNOLOGIES, INC.
18 Nov 2025
Form 4
Glass Mitchell
17 Nov 2025
Form 4
White Billy Joe
17 Nov 2025
Form 4
Silverman Joshua
14 Nov 2025
Form 4
Friscia Stephen
14 Nov 2025
Form 4
Bernstein Bruce
14 Nov 2025
Select Filings
Non-Ownership Filings
(407)
Expand
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
05:00PM
8-K
Entry into a Material Definitive Agreement
18 Sep
8-K
Termination of a Material Definitive Agreement
11 Sep
10-Q
Q2
ended 30 Jun 2026
12 Aug
8-K
Termination of a Material Definitive Agreement
2 Jul
10-Q
Q1
ended 31 Mar 2026
15 May
10-K/A
FY 2025
ended 31 Dec 2025
29 Apr
10-K
FY 2025
ended 31 Dec 2025
15 Apr
NT 10-K
FY 2025
ended 31 Dec 2025
31 Mar
8-K
Changes in Registrant's Certifying Accountant
13 Mar
EFFECT
Notice of effectiveness
18 Feb
CORRESP
Filing review correspondence
12 Feb
S-3
Registration statement (primary offering)
11 Feb
8-K
Entry into a Material Definitive Agreement
23 Jan
DRS
Draft registration statement
23 Jan
8-K
Entry into a Material Definitive Agreement
9 Dec 2025
424B3
Prospectus filing (Rule 424(b)(3))
1 Dec 2025
EFFECT
Notice of effectiveness
1 Dec 2025
CORRESP
Filing review correspondence
25 Nov 2025
10-Q
Q3
ended 30 Sept 2025
19 Nov 2025
Ownership Filings
(171)
Expand
Form 4
Silverman Joshua
2 Oct
Form 4/A
Silverman Joshua
2 Oct
Form 3
Ehrlichman Yossef
22 Sep
Form 3
Fagan Charles Todd
17 Aug
Form 4
Voss Chelsea Sierra
14 May
Form 4
Friscia Stephen
15 Apr
Form 4
Voss Chelsea Sierra
15 Apr
Form 4
Glass Mitchell
15 Apr
Form 4
White Billy Joe
15 Apr
Form 4
Bernstein Bruce
15 Apr
Form 4
Silverman Joshua
15 Apr
Form 4
Voss Chelsea Sierra
30 Jan
Form 3
Voss Chelsea Sierra
30 Jan
Form 4
PharmaCyte Biotech, Inc.
18 Nov 2025
SC 13D/A
Q/C TECHNOLOGIES, INC.
18 Nov 2025
Form 4
Glass Mitchell
17 Nov 2025
Form 4
White Billy Joe
17 Nov 2025
Form 4
Silverman Joshua
14 Nov 2025
Form 4
Friscia Stephen
14 Nov 2025
Form 4
Bernstein Bruce
14 Nov 2025
Ask in Filing
Ask in Filing